Dry Skin (Xerosis Cutis): Causes, Treatments & When to See a Doctor

## Overview Dry skin — known medically as **xerosis cutis** (ICD-10: L85.3) — is a very common condition characterised by rough, flaky, tight, or cracked skin caused by insufficient moisture in the outermost layer of the epidermis, the *stratum corneum*. It can appear anywhere on the body but most frequently affects the shins, forearms, hands, and lateral aspects of the trunk. Xerosis is one of the most prevalent dermatological complaints worldwide. Population-based surveys suggest that **29–85 %** of adults experience dry skin at some point each year, with prevalence rising sharply after age 60 [1]. In elderly populations living in temperate climates, xerosis affects an estimated **50–75 %** of individuals over 65 years [2]. The wide prevalence range reflects differences in climate, occupation, bathing habits, and diagnostic thresholds across studies. People search for information on dry skin because it can be uncomfortable (itching, stinging, cosmetic concern), may signal an underlying medical condition, and is often easily managed once the cause is understood. This article provides an evidence-based overview of causes, self-care strategies, medications, and clear guidance on when professional evaluation is warranted. --- ## Common Causes The stratum corneum functions as a water-retention barrier composed of corneocytes embedded in an intercellular lipid matrix — often described as the "brick and mortar" model [3]. Dry skin results when this barrier is disrupted, natural moisturising factor (NMF) levels decline, or transepidermal water loss (TEWL) increases. Causes are listed below roughly in order of frequency. ### 1. Environmental and Behavioural Factors (Most Common) - **Low humidity and cold weather** — heating systems in winter reduce indoor humidity to 15–20 %, accelerating water evaporation from skin. - **Excessive bathing or hot water** — prolonged exposure to hot water strips the skin of protective lipids, increasing TEWL [4]. - **Harsh soaps and detergents** — alkaline cleansers disrupt the acid mantle (pH ~4.5–5.5) and emulsify intercellular lipids. - **Occupational exposure** — healthcare workers, hairdressers, food handlers, and construction workers experience chronic irritant contact dermatitis. ### 2. Ageing (Senile Xerosis) With ageing, sebaceous gland output declines, epidermal lipid synthesis decreases, and NMF production falls. Filaggrin — the protein precursor of NMF — is expressed at lower levels in older adults, contributing to barrier impairment [5]. These changes make xerosis nearly universal in elderly populations. ### 3. Atopic Dermatitis and Eczema Genetically driven filaggrin loss-of-function mutations (found in 20–50 % of atopic dermatitis patients) reduce NMF and impair barrier integrity [5]. Xerosis is a hallmark feature and often the earliest sign of atopic dermatitis, even before inflammatory flares. ### 4. Contact Dermatitis (Irritant) Repeated exposure to water, solvents, or cleaning agents causes cumulative damage to the lipid barrier. This is a leading cause of hand xerosis and occupational dermatitis. ### 5. Systemic Diseases - **Hypothyroidism** — reduced thyroid hormone decreases sebaceous secretion and epidermal turnover. - **Diabetes mellitus** — autonomic neuropathy decreases sweating; hyperglycaemia promotes osmotic dehydration of the skin. - **Chronic kidney disease** — uraemia alters sweat gland function, reduces sebum production, and depletes skin hydration. - **Iron-deficiency anaemia** — may present with generalised pruritus and xerosis. ### 6. Medications Several drug classes are well-recognised causes of xerosis: - **Retinoids** (isotretinoin, tretinoin) — increase epidermal turnover faster than barrier repair. - **Diuretics** — systemic dehydration secondarily affects skin hydration. - **Statins** — may interfere with cholesterol synthesis in the epidermal barrier. - **Targeted cancer therapies** (EGFR inhibitors) — xerosis occurs in up to 35 % of patients. ### 7. Nutritional Deficiencies Deficiencies in essential fatty acids, zinc, and vitamins A and D can impair keratinocyte differentiation and lipid synthesis, contributing to xerosis. ### 8. Dermatological Conditions - **Psoriasis** — abnormal keratinocyte proliferation produces dry, scaly plaques. - **Ichthyosis** — a group of inherited keratinisation disorders featuring diffuse scaling. --- ## RED FLAGS Most dry skin is benign and manageable at home. However, seek **immediate or same-day medical attention** if dry skin is accompanied by any of the following: - **Cracked skin with signs of infection** — increasing redness, warmth, swelling, pus, red streaking, or fever (≥ 38 °C / 100.4 °F), which may indicate cellulitis requiring urgent antibiotics - **Severe, widespread cracking and bleeding** that does not respond to moisturisers within 1–2 weeks - **Intense, unrelenting itch that disrupts sleep** or daily functioning — may indicate systemic disease - **Unexplained weight loss, fatigue, or excessive thirst** alongside new-onset xerosis — screen for diabetes, thyroid disease, or malignancy - **Rapidly progressive rash or blistering** — may indicate a serious dermatological emergency - **Generalised dry skin in a child under 2 years** with failure to thrive — warrants paediatric evaluation - **New-onset generalised xerosis in a patient on immunosuppressive or chemotherapy agents** — may require dose adjustment --- ## Self-Care at Home The cornerstone of xerosis management is **restoring and maintaining the skin barrier**. The following evidence-based measures are recommended [1][4][6]: ### Bathing Habits - Limit showers or baths to **5–10 minutes** using **lukewarm** (not hot) water. - Use a **soap-free, fragrance-free, pH-balanced cleanser** (syndet bars or gentle liquid washes). - Pat skin dry gently; do **not** rub with a towel. - Apply moisturiser **within 3 minutes** of bathing ("soak and seal" method) to trap water in the stratum corneum. ### Moisturiser Selection Moisturisers work through three mechanisms, often combined in a single product [4]: | Mechanism | How It Works | Key Ingredients | |---|---|---| | **Occlusive** | Forms a physical barrier to reduce TEWL | Petrolatum, dimethicone, lanolin, mineral oil | | **Humectant** | Draws water from the dermis and environment into the stratum corneum | Glycerol (glycerin), urea, hyaluronic acid, lactic acid | | **Emollient** | Fills gaps between corneocytes, smoothing skin texture | Ceramides, fatty acids, cholesterol, squalane | Petrolatum (petroleum jelly) remains the most effective single occlusive agent, reducing TEWL by up to **98 %** [4]. Ceramide-containing moisturisers may offer additional benefit by replenishing the intercellular lipid matrix and are particularly recommended for atopic dermatitis–related xerosis. ### Environmental Adjustments - Use a **room humidifier** to maintain indoor humidity at **40–60 %** during winter months. - Wear **cotton or soft-fibre clothing**; avoid direct wool contact on irritated skin. - Wear **gloves** when handling cleaning products, solvents, or when hands are in water for extended periods. ### Dietary Considerations - Maintain adequate hydration (generally **1.5–2 L of fluids daily** for most adults). - Ensure sufficient intake of **omega-3 fatty acids** (oily fish, flaxseed), **zinc**, and **vitamins A and D** through diet or supplementation if deficient. --- ## OTC Medications That Help Over-the-counter (OTC) topical products for dry skin generally fall into the categories below. These are generally safe for most adults but should be used per label instructions. | Class | Example Products | Typical Adult Use | Mechanism | Notes / Contraindications | |---|---|---|---|---| | **Petrolatum-based emollients** | Vaseline, Aquaphor Healing Ointment | Apply liberally to affected areas 1–3× daily | Occlusive — reduces TEWL by up to 98 % | May feel greasy; generally very well tolerated. Avoid on acne-prone facial skin in some individuals | | **Ceramide-containing creams** | CeraVe Moisturising Cream, Cetaphil PRO Eczema Soothing Moisturiser | Apply 1–2× daily, especially after bathing | Replenishes intercellular lipids (ceramides, cholesterol, fatty acids) | Suitable for sensitive and eczema-prone skin. Generally no significant contraindications | | **Urea creams (2–10 %)** | Eucerin UreaRepair, Flexitol Intensely Nourishing Cream | Apply 1–2× daily to affected areas | Humectant and mild keratolytic — draws water into stratum corneum and gently exfoliates | Avoid on broken or acutely inflamed skin (may sting). Higher concentrations (20–40 %) available but may require guidance | | **Lactic acid creams (5–12 %)** | AmLactin Daily Moisturising Lotion (12 % ammonium lactate) | Apply 1–2× daily | Alpha-hydroxy acid — humectant and mild keratolytic | May cause mild stinging on application; avoid on open wounds or face. Use sunscreen, as AHAs may increase photosensitivity | | **Colloidal oatmeal preparations** | Aveeno Dermexa, various bath additives | Apply as cream or add to bath per package directions | Anti-inflammatory and barrier-protective; contains avenanthramides | Generally very safe. Rare oat allergy possible | | **Hydrocortisone 1 % cream** (short-term) | Cortizone-10, generic | Apply thin layer to itchy areas up to 2× daily for **≤ 7 days** | Anti-inflammatory — reduces itch and erythema | Do not use on the face, groin, or axillae for extended periods. Not for long-term use without medical supervision. Avoid in skin infections | | **Oral antihistamines** (for itch) | Cetirizine 10 mg, diphenhydramine 25–50 mg | Cetirizine: 10 mg once daily; diphenhydramine: 25–50 mg at bedtime | H₁-receptor antagonism reduces histamine-mediated itch | Diphenhydramine causes sedation (may aid sleep-disrupting itch). Avoid diphenhydramine in elderly (Beers Criteria). Cetirizine preferred for daytime use | > **Note:** If OTC measures fail to improve symptoms within **2–3 weeks** of consistent use, medical evaluation is recommended. --- ## Prescription Options Prescription therapy is generally reserved for xerosis that is refractory to consistent OTC moisturisation, is associated with an underlying condition, or is complicated by significant inflammation or infection. | Class | Examples | Indication | Prescriber | Key Notes | |---|---|---|---|---| | **Topical corticosteroids (medium-to-high potency)** | Triamcinolone 0.1 % cream, betamethasone valerate 0.1 % | Xerosis with significant eczematous inflammation | GP, dermatologist | Use for defined courses (typically 1–2 weeks on, then taper). Risk of skin atrophy with prolonged use | | **Topical calcineurin inhibitors** | Tacrolimus 0.03–0.1 % ointment, pimecrolimus 1 % cream | Steroid-sparing maintenance in atopic xerosis, especially facial or intertriginous areas | Dermatologist, GP | FDA black-box warning regarding theoretical malignancy risk (though post-marketing data generally reassuring). Avoid in active skin infections | | **Prescription-strength urea (20–40 %)** | Urea 40 % cream (Carmol 40), urea 20 % cream | Severe xerosis, hyperkeratotic skin, ichthyosis | GP, dermatologist | Potent keratolytic; may sting on application. Avoid on broken or inflamed skin | | **Topical retinoids** | Tretinoin 0.025–0.05 % cream, tazarotene | Xerosis with photoageing or keratinisation disorders | Dermatologist | Paradoxically may worsen dryness initially; concurrent moisturiser use essential. Contraindicated in pregnancy (Category X) | | **Crisaborole 2 % ointment** | Eucrisa | Mild-to-moderate atopic dermatitis with xerosis (age ≥ 3 months) | Dermatologist, GP | PDE4 inhibitor; non-steroidal anti-inflammatory. Application-site burning is the most common side effect | | **Dupilumab (injection)** | Dupixent | Moderate-to-severe atopic dermatitis not controlled with topical therapy | Dermatologist, allergist | IL-4/IL-13 monoclonal antibody. Significant efficacy for itch and xerosis in atopic dermatitis. Risk of conjunctivitis | | **Systemic thyroid hormone / disease-specific therapy** | Levothyroxine (for hypothyroidism), insulin optimisation (for diabetes) | Xerosis driven by underlying systemic disease | Endocrinologist, GP | Treating the root cause often resolves xerosis. Thyroid function or glycaemic control should be optimised | --- ## Lab Tests Typically Ordered Laboratory investigation is generally not required for mild, seasonal dry skin that responds to moisturisation. Testing is indicated when xerosis is **generalised, persistent, severe, or accompanied by systemic symptoms**. | Test | Rationale | When to Consider | |---|---|---| | **Thyroid function tests** (TSH, free T4) — [more info](/tests/thyroid-function-tests) | Hypothyroidism is a common reversible cause of generalised xerosis | New-onset diffuse xerosis with fatigue, weight gain, cold intolerance, constipation | | **Fasting blood glucose / HbA1c** — [more info](/tests/hba1c) | Diabetes mellitus causes xerosis via autonomic neuropathy and dehydration | Xerosis with polydipsia, polyuria, or known diabetic risk factors | | **Renal function panel** (BUN, creatinine, eGFR) — [more info](/tests/kidney-function-tests) | Chronic kidney disease / uraemia causes pruritus and xerosis | Generalised itch and dry skin with oedema, hypertension, or known renal risk factors | | **Complete blood count (CBC)** — [more info](/tests/complete-blood-count) | Iron-deficiency anaemia can present with pruritus and dry skin | Xerosis with pallor, fatigue, or unexplained itch | | **Serum iron, ferritin, TIBC** — [more info](/tests/iron-studies) | Confirms iron deficiency if CBC suggests anaemia | Abnormal CBC or strong clinical suspicion | | **Vitamin D level** (25-hydroxyvitamin D) — [more info](/tests/vitamin-d) | Vitamin D deficiency may impair skin barrier function | Severe or refractory xerosis, limited sun exposure, risk groups | | **Liver function tests** (ALT, AST, bilirubin, ALP) — [more info](/tests/liver-function-tests) | Cholestatic liver disease can cause pruritus and secondary xerosis | Itch with jaundice or hepatomegaly | | **Skin biopsy** | To rule out ichthyosis, psoriasis, cutaneous T-cell lymphoma, or other dermatoses | Atypical presentation, refractory to treatment, clinical suspicion of malignancy | --- ## Special Populations ### Children and Infants - Xerosis is extremely common in children, particularly those with atopic dermatitis (prevalence 15–20 % in children worldwide). - **Emollients** are first-line and should be applied liberally and frequently — at least 2–3 times daily [6]. - Avoid fragranced products and harsh soaps. Use soap-free cleansers. - **OTC hydrocortisone 1 %** may be used for short periods (up to 7 days) for mild eczematous flares in children ≥ 2 years. For younger children, consult a paediatrician before using any topical corticosteroid. - **Do not** apply urea-containing products to infants without medical guidance, as the stinging may be significant and safety data are limited in very young children. - Paediatric dosing of oral antihistamines varies by age and weight — always follow product labelling or a clinician's instructions. ### Pregnancy - Xerosis is common during pregnancy due to hormonal changes and increased transepidermal water loss. - **Emollients and petrolatum** are generally considered safe in pregnancy and are first-line. - **Topical retinoids** (tretinoin, tazarotene) are **contraindicated** in pregnancy (FDA former Category X) due to teratogenic risk. - **Topical corticosteroids**: mild-to-moderate potency (e.g., hydrocortisone 1 %) are generally considered low-risk. Avoid potent or very potent topical steroids, especially over large areas or for prolonged periods, without obstetric guidance. - **Tacrolimus and pimecrolimus**: limited human data in pregnancy; generally avoid unless the benefit clearly outweighs the risk — consult prescriber. - ACOG does not publish specific guidance on xerosis, but recommends minimising unnecessary medication exposure during pregnancy. ### Elderly (≥ 65 Years) - Senile xerosis is near-universal and is the **most common cause of pruritus in older adults**. - Emollients should be applied daily as a routine preventive measure. - **Avoid sedating antihistamines** (diphenhydramine, hydroxyzine) in the elderly due to anticholinergic burden, fall risk, and cognitive impairment (American Geriatrics Society Beers Criteria) [7]. - Monitor for medication-induced xerosis (diuretics, statins, retinoids). - Cracked dry skin on the feet is a significant risk factor for **cellulitis** in older adults with peripheral vascular disease or diabetes — prompt moisturisation and wound care are essential. ### Athletes - Frequent showering, chlorinated pool water, and low-humidity training environments predispose athletes to xerosis. - Apply a fragrance-free moisturiser immediately after showering. - Use a gentle, pH-balanced cleanser rather than antibacterial soap. - Swimmers should rinse chlorinated water off promptly and apply an emollient. - Friction from sporting equipment may exacerbate xerosis in localised areas — barrier creams or protective clothing can help. --- ## When to Escalate Use the following thresholds to determine the appropriate level of care: ### Self-Care (Continue Home Management) - Mild, localised dry skin that responds to moisturiser within 1–2 weeks - Seasonal dryness without cracking, bleeding, or significant itch ### Same-Day or Scheduled GP Appointment (Within 1–2 Weeks) - Xerosis persisting **> 2–3 weeks** despite consistent moisturisation - Dry skin accompanied by significant itch that disrupts daily activities or sleep - Suspicion of an underlying systemic cause (new fatigue, weight change, excessive thirst) - Dry, cracked skin on the feet in a patient with diabetes (infection prevention) - Xerosis that began after starting a new medication ### Urgent Care (Same Day) - Cracked skin with early signs of **secondary infection** — localised redness, warmth, tenderness, minor discharge — that is not yet systemic - Widespread, severe xerosis with painful fissures limiting hand or foot function ### Emergency Department - Signs of **systemic infection / cellulitis** — spreading redness, red streaking (lymphangitis), fever, chills, rapid heart rate - Severe allergic reaction or drug reaction with widespread skin involvement (e.g., erythroderma) --- ## References [1] White-Chu EF, Reddy M. Dry skin in the elderly: complexities of a common problem. *Clin Dermatol*. 2011;29(1):37–42. PMID:21146730. [2] Paul C, Maumus-Robert S, Mazereeuw-Hautier J, Guyen CN, Saudez X, Schmitt AM. Prevalence and risk factors for xerosis in the elderly: a cross-sectional epidemiological study in primary care. *Dermatology*. 2011;223(3):260–265. PMID:22105073. [3] Elias PM. Stratum corneum defensive functions: an integrated view. *J Invest Dermatol*. 2005;125(2):183–200. PMID:16098026. [4] Rawlings AV, Harding CR. Moisturization and skin barrier function. *Dermatol Ther*. 2004;17 Suppl 1:43–48. PMID:14728698. [5] Thyssen JP, Kezic S. Causes of epidermal filaggrin reduction and their role in the pathogenesis of atopic dermatitis. *J Allergy Clin Immunol*. 2014;134(4):792–799. PMID:25065719. [6] Lodén M. The clinical benefit of moisturizers. *J Eur Acad Dermatol Venereol*. 2005;19(6):672–688. PMID:16268870. [7] American Geriatrics Society 2023 Updated AGS Beers Criteria for Potentially Inappropriate Medication Use in Older Adults. *J Am Geriatr Soc*. 2023;71(7):2052–2081. PMID:37139824. [8] National Institute for Health and Care Excellence (NICE). Emollients: prescribing information. NICE Clinical Knowledge Summary. Updated 2023. Available at: https://cks.nice.org.uk/topics/dermatitis-contact/prescribing-information/emollients/. [9] Proksch E, Berardesca E, Misery L, Engblom J, Bouwstra J. Dry skin management: practical approach in light of latest research on skin structure and function. *J Dermatolog Treat*. 2020;31(7):716–722. PMID:30887844. --- *This article is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional for diagnosis and treatment of any medical condition.*